Literature DB >> 27208817

Medium-term Outcomes of Urolift (Minimum 12 Months Follow-up): Evidence From a Systematic Review.

Patrick Jones1, G N Rajkumar2, Bhavan Prasad Rai3, Omar M Aboumarzouk4, Paul Cleaveland5, Shalom J Srirangam5, Bhaskar K Somani6.   

Abstract

The urolift device has emerged as a novel intervention for men with lower urinary tract symptoms secondary to benign prostatic hyperplasia, and in recent years there has been an increasing amount of primary research published on it. However, critical medium-term appraisal remains lacking. Our objective was to perform a systematic review and therefore identify, appraise, and synthesize the existing evidence for the minimally invasive technique.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27208817     DOI: 10.1016/j.urology.2016.05.003

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

Review 1.  Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia.

Authors:  Jennifer Westwood; Robert Geraghty; Patrick Jones; Bhavan P Rai; Bhaskar K Somani
Journal:  Ther Adv Urol       Date:  2018-08-12

2.  Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Balaji Reddy; Karen Ann McCutcheon; Michael Borofsky; Vikram Narayan; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-05-25

3.  TURP in the era of UroLift.

Authors:  Deepak Batura; Iqbal Sahibzada
Journal:  Int Urol Nephrol       Date:  2018-03-01       Impact factor: 2.370

Review 4.  UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia.

Authors:  Patrick Jones; Bhavan P Rai; Omar Aboumarzouk; Bhaskar K Somani
Journal:  Ther Adv Urol       Date:  2016-10-10

Review 5.  Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia.

Authors:  Karthik Tanneru; Shiva Gautam; Daniel Norez; Jatinder Kumar; Muhammad Umar Alam; Shahriar Koocheckpour; K C Balaji; Costa Joseph
Journal:  Int Urol Nephrol       Date:  2020-02-17       Impact factor: 2.370

Review 6.  Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies.

Authors:  Daniel Christidis; Shannon McGrath; Marlon Perera; Todd Manning; Damien Bolton; Nathan Lawrentschuk
Journal:  Prostate Int       Date:  2017-01-19

Review 7.  The industrial revolution for the management of benign prostate obstruction: worldwide publication trends for surgical and medical therapies over the past two decades.

Authors:  Jeremy Nettleton; Patrick Jones; Amelia Pietropaolo; Robert Geraghty; Bhavan Rai; Marcus Drake; Laurian Dragos; Domenico Veneziano; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2019-04-26

8.  Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.

Authors:  Giampaolo Siena; L Cindolo; G Ferrari; D Maruzzi; G Fasolis; S V Condorelli; F Varvello; F Visalli; S Rabito; S Toso; S Caroassai; A Mari; L Viola; B K Somani; M Carini
Journal:  World J Urol       Date:  2021-03-31       Impact factor: 4.226

9.  Evaluation of Clinical Outcomes of Prostatic Urethral Lift for Benign Prostatic Hyperplasia: An Asian Population Study.

Authors:  Jeong Ho Kim; Ki Soo Lee; Tae Hyo Kim
Journal:  World J Mens Health       Date:  2019-07-30       Impact factor: 5.400

Review 10.  An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy.

Authors:  Aditya Srinivasan; Run Wang
Journal:  World J Mens Health       Date:  2019-08-20       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.